|
Market Cap | 36.47M | EPS (ttm) | -0.34 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | - | EPS next 5Y | - |
P/B | 1.34 | EPS Q/Q | 50.35% |
Dividend | - | Sales Q/Q | - |
Insider Own | 59.02% | Inst Own | 11.84% |
Insider Trans | 0.00% | Inst Trans | - |
Short Float | 0.84% | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 181.68K | 52W Range | 4.02 - 18.56 |
|
|
|
Veea, Inc. is a Platform-as-a-Service (PaaS) company, which engages in the sale of smart computing hubs and related subscriptions and licenses. Its solutions include digital inclusion, connected buildings, precision agriculture, TROLLEE, and Internet-of-Things (IoT) and Industrial internet of things (IIoT) connectivity. The company was founded by Allen B. Salmasi and Michael Salmasi in 2014 and is headquartered in New York, NY. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
SMITH JANICE K. | COO and Interim CFO | Sep 17 '24 | Option Exercise | 3.01 | 25,000 | 75,250 | 83,645 | Sep 25 08:12 PM |
|
|
|
|
Market Cap | 14.99M | EPS (ttm) | 0.39 |
P/E | 0.76 | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | 42.87% |
P/S | 0.12 | EPS next 5Y | - |
P/B | 0.04 | EPS Q/Q | 397.39% |
Dividend | - | Sales Q/Q | -23.32% |
Insider Own | 62.06% | Inst Own | 0.16% |
Insider Trans | 0.00% | Inst Trans | 4.28% |
Short Float | 6.34% | Earnings | - |
Analyst Recom | 1.00 | Target Price | 12.00 |
Avg Volume | 1.53M | 52W Range | 0.37 - 7.50 |
|
|
|
BAIYU Holdings, Inc. engages in the sale of metal products and provision of supply chain solutions. It operates through the Commodities Trading Business and Supply Chain Services segments. The company was founded on December 19, 2011, and is headquartered in Shenzhen, China. |
|
|
|
Market Cap | 10.73M | EPS (ttm) | -0.01 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | 0.16 | EPS next 5Y | - |
P/B | 1.93 | EPS Q/Q | -220.63% |
Dividend | - | Sales Q/Q | -48.15% |
Insider Own | 42.94% | Inst Own | 0.07% |
Insider Trans | 0.00% | Inst Trans | -65.86% |
Short Float | 1.92% | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 2.13M | 52W Range | 0.50 - 35.44 |
|
|
|
U-BX Technology Ltd. provides digital promotion, risk assessment and value-added bundled benefit services. It is a holding company, which focuses on providing value-added services using artificial intelligence-driven technology to businesses within the insurance industry, including insurance carriers, and brokers. The company was founded by Jian Chen n 2018 and is headquartered in Beijing, China. |
|
| |
|
Market Cap | - | EPS (ttm) | - |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | - | EPS next 5Y | - |
P/B | - | EPS Q/Q | - |
Dividend | - | Sales Q/Q | - |
Insider Own | - | Inst Own | - |
Insider Trans | - | Inst Trans | - |
Short Float | - | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 268.48K | 52W Range | 4.03 - 5.49 |
|
|
|
|
|
Market Cap | 4.36M | EPS (ttm) | -4.36 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | 27.59% |
P/S | 9.47 | EPS next 5Y | - |
P/B | 2.22 | EPS Q/Q | 19.17% |
Dividend | - | Sales Q/Q | 3183.33% |
Insider Own | 22.07% | Inst Own | 1.56% |
Insider Trans | 0.00% | Inst Trans | - |
Short Float | 0.90% | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 37.60K | 52W Range | 3.90 - 22.58 |
|
|
|
Wearable Devices Ltd. engages in the development of a non-invasive neural input technology that allows operation and control of digital devices using subtle finger movements and fingertip pressure. It offers Mudra band, a neutral input wristband. The company was founded by Asher Dahan, Guy Wagner, and Leeor Langer in March 2014 and is headquartered in Yokne'am Illit, Israel. |
|
| |
|
Market Cap | 19.53M | EPS (ttm) | - |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | - | EPS next 5Y | - |
P/B | - | EPS Q/Q | 255.13% |
Dividend | - | Sales Q/Q | - |
Insider Own | 31.22% | Inst Own | 2.08% |
Insider Trans | 0.00% | Inst Trans | - |
Short Float | 0.12% | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 8.34M | 52W Range | 0.11 - 0.94 |
|
|
|
noco-noco, Inc. provides decarbonization solutions. It offers X-SEPA, a battery separator technology which helps in energy management. The company was founded in 2019 and is headquartered in Singapore. |
|
|
|
Market Cap | 6.01M | EPS (ttm) | -1.15 |
P/E | - | EPS this Y | 30.67% |
Forward P/E | - | EPS next Y | 4.57% |
PEG | - | EPS past 5Y | 30.25% |
P/S | 12.02 | EPS next 5Y | - |
P/B | 0.27 | EPS Q/Q | 46.77% |
Dividend | - | Sales Q/Q | -85.75% |
Insider Own | 6.69% | Inst Own | 30.02% |
Insider Trans | -0.94% | Inst Trans | -26.79% |
Short Float | 6.83% | Earnings | Aug 13/a |
Analyst Recom | 2.00 | Target Price | 2.17 |
Avg Volume | 4.45M | 52W Range | 0.06 - 3.17 |
|
|
|
Gritstone bio, Inc. clinical-stage biotechnology company, which engages in developing the next generation of cancer immunotherapies to fight multiple cancer types. The company was founded by Andrew Allen, Timothy Chan, Mark Cobbold, Graham Lord, Naiyer Rizvi and Jean-Charles Soria in August 2015 and is headquartered in Emeryville, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Allen Andrew R | PRESIDENT AND CEO | May 16 '24 | Sale | 0.75 | 24,263 | 18,156 | 985,360 | May 17 09:58 PM | Jones Erin | EVP, CHIEF OPERATING OFFICER | May 16 '24 | Sale | 0.75 | 13,749 | 10,288 | 359,293 | May 17 09:57 PM | Jooss Karin | SEE REMARKS | May 16 '24 | Sale | 0.75 | 13,749 | 10,288 | 683,526 | May 17 09:57 PM | Hawryluk Matthew | EVP, CHIEF BUSINESS OFFICER | May 16 '24 | Sale | 0.75 | 9,259 | 6,929 | 313,931 | May 17 09:56 PM | Economides Vassiliki | EVP, CHIEF FINANCIAL OFFICER | May 16 '24 | Sale | 0.75 | 13,749 | 10,288 | 262,437 | May 17 09:55 PM |
|
|
| |
|
Market Cap | 5.79M | EPS (ttm) | -4.00 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | 0.59 | EPS next 5Y | - |
P/B | 0.05 | EPS Q/Q | -1843.00% |
Dividend | - | Sales Q/Q | 549.66% |
Insider Own | 4.44% | Inst Own | 0.03% |
Insider Trans | 0.00% | Inst Trans | -70.60% |
Short Float | 2.36% | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 2.35M | 52W Range | 0.17 - 4.90 |
|
|
|
Shineco, Inc. is a holding company, which through its subsidiaries, engages in the production and distribution of plant-based products. It operates through the following segments: Rapid Diagnostic and Other, Other Agricultural, and Healthy Meals Products. The Rapid Diagnostic and Other Products segment is conducted through Biowin, which specializes in the development, production and distribution of innovative rapid diagnostic products and related medical devices for the most common diseases. The Other Agricultural Products segment is conducted through Wintus, which specializes in producing, processing and distribution of agricultural products, such as silk and silk fabrics as well as trading of fresh fruit. The Healthy Meals Products segment is conducted through Fuzhou Meida, which specializes in developing healthy meals for people with slow metabolic health and those in recovery from metabolic disorders. The company was founded on August 20, 1997 and is headquartered in Beijing, China. |
|
|
|
Market Cap | 16.06M | EPS (ttm) | -0.93 |
P/E | - | EPS this Y | 4.07% |
Forward P/E | - | EPS next Y | 6.06% |
PEG | - | EPS past 5Y | -21.09% |
P/S | - | EPS next 5Y | - |
P/B | 0.70 | EPS Q/Q | -10.15% |
Dividend | - | Sales Q/Q | - |
Insider Own | 15.78% | Inst Own | 13.31% |
Insider Trans | 0.00% | Inst Trans | -22.53% |
Short Float | 1.57% | Earnings | Aug 08/b |
Analyst Recom | 1.33 | Target Price | 7.50 |
Avg Volume | 1.10M | 52W Range | 0.38 - 2.95 |
|
|
|
Cognition Therapeutics, Inc. is a clinical stage neuroscience company which engages in developing drugs that help restore normal cellular damage responses in neurodegenerative and neuro-ophthalmic disorders. It offers the CT1812 which aims to restore the damaged cellular processes that drive diseases such as Alzheimer's disease, dry age-related macular degeneration, geographic atrophy and other conditions. The company was founded by Franz F. Hefti, Gilbert M. Rishton, and Susan M. Catalano on August 21, 2007 and is headquartered in Purchase, NY. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Ricciardi Lisa | CEO & President | Mar 14 '24 | Buy | 1.75 | 5,700 | 9,975 | 291,345 | Mar 14 04:34 PM |
|
|
|
|
Market Cap | 1.10M | EPS (ttm) | -0.14 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | - | EPS next 5Y | - |
P/B | 0.43 | EPS Q/Q | -204.38% |
Dividend | - | Sales Q/Q | - |
Insider Own | 57.06% | Inst Own | 32.03% |
Insider Trans | 0.00% | Inst Trans | - |
Short Float | 9.87% | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 2.54M | 52W Range | 0.31 - 13.56 |
|
|
|
Silexion Therapeutics Corp. engages in the discovery and development of treatments for KRAS-driven cancers. The company is headquartered in Modiin, Israel. |
|
|